Home > Boards > US OTC > Medical - Drugs >

Acusphere, Inc. (ACUS)

Add ACUS Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 10/5/2017 8:06:07 PM - Followers: 22 - Board type: Free - Posts Today: 0

Update 01.20.2011

Today : Friday 20 January 2012

Acusphere, Inc. (ACUS.PK) today announced that its stockholders voted to approve the proposed 1-for-10 reverse stock split of the Company's common stock at its Special Meeting of Stockholders held today. 

See post 749 for press release, also currently a sticky post.

End Update 01.20.2012

Update 12.23.2011

Proxy Notice Of Special Meeting Received via US Mail.  Posted a sticky on some highlights, I can't find a link to it on the ACUS website but one can likely find it searching the SEC, maybe?

They are asking for a 1-10 reverse stock split.  The proxy has lots of interesting stuff in it.  Maybe someone can find a link to it and post it.......

End Update 12.23.2011

Update 12.20.2011

Another Letter to the Shareholders was issued yesterday and can be read as the first sticky post.

A line from the letter is:

"We have now arrived at an important juncture, and we need your support to help effect a reverse stock split to allow the Company to finance the completion of our strategic direction."

So a reverse split may be coming.  I have lightened up on my own shares but as of now still hold some and may buy or sell more as the future unfolds.

End 12.20.2011 update.

Update 10.07.2011

Imagify was shot down by the FDA advisory panel a couple years ago ,give or take a little, I think it was 16-1, mainly because Imagify had not been tested against a placebo.  They had run trials against the "Standard Of Care," Nuke testing.

On June 8th 2011 ACUS announced that Imagify has been granted a SPA by the FDA for an addtional phase III against a placebo.

Also on June 8th  2011 ACUS announced that they hoped to complete their work to the EU for an MMA application for Imagify in the 2nd half of 2011.

You can read about these latest developments here, and I will try to figure out how to make this post a sticky.

Since I-Hub did away with their spell checker I no longer run my posts through one, so I apoligize to those who may be offened by this fact, in advance.

End of 10.07.2011 update.


Description:Imagify is a cardiovascular drug for the detection of coronary artery disease, the leading cause of death in the United States & Europe.

Partnership Agreement : On October 24, 2008, Acusphere, Inc. (the "Company") announced the signing of a definitive agreement with Cephalon, Inc. ("Cephalon") to provide $20 million in upfront financing by purchasing a $15 million senior secured convertible note and by paying a $5 million upfront fee for an exclusive worldwide license to AI-525, a preclinical-stage injectable formulation of celecoxib using Acusphere's proprietary Hydrophobic Drug Delivery System (HDDS?) technology.   On July 7, 2004, Acusphere announced a $70 million partnership for European development and marketing rights to Nycomed. From this partnership, Acusphere has currently received $12 million in milestone payments. An additional $58 million in milestone payments are related to regulatory approvals and achievement of certain sales goals.

Market Potential & Competition : The potential market in the US for Imagify is estimated to be roughly $2 billion annually. It is estimated that more than 10 million procedures are done each year in the U.S. to detect coronary artery disease. The leading procedure to detect coronary heart disease is nuclear stress testing, which costs roughly double the amount to implement, takes significantly more time to administer, and is arguably more harmful to the patient/environment.

FDA response : The FDA granted ACUS an Advisory Panel Meeting for Imagify on December 10th, 2008.  The panel voted against recommendation by a vote of 16-1.  The PDUFA date is set for February 28, 2009. On this date the FDA will decide whether or not they approve of the drug.  The company is also working with Nycomed to submit its MAA filing in Europe.

Description: AI-850 is a Phase 1 clinical trial completed product candidate that utilizes hydrophobic drug delivery system to improve the dissolution rate of a cancer drug.
On March 31, Acusphere licensed the property rights to its Hydrophobic Drug Delivery System™ (HDDS) for oncology applications to Cephalon for $10 million. Per the last conference call, the company may choose to license out the HDDS system to other companies for other applications. (Oncology is only one of the potential applications.)

If you would like to listen to Acusphere's most current conference calls or presentations, please go to the following:

Current share count:

Authorized Common Stock: 250 million shares
Outstanding Common Stock: 49.51 million shares
Preferred Stock convertible to common: 25.2 million shares

Acusphere, Inc., a specialty pharmaceutical company, develops new drugs and formulations of existing drugs using its proprietary porous microparticle technology in the United States. Its porous microparticle technology enables to control the size and porosity of particles, including nanoparticles and microparticles. The company develops products in the areas of cardiology, oncology, and asthma. Its lead product candidate Imagify, a cardiovascular drug, is in Phase 3 clinical development for the detection of coronary artery disease. The company?s products also include AI-850, a Phase 1 clinical trial completed product candidate that utilizes hydrophobic drug delivery system to improve the dissolution rate of a cancer drug; AI-128, a Phase 1 clinical study completed formulation of asthma drug. Acusphere was founded in 1993 and is headquartered in Watertown, Massachusetts.



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#813   Who sold out today? this stock could be carldfw 10/05/17 08:06:06 PM
#812   Saw ACUS website is no longer active. Don't Hokane 11/30/15 09:57:28 AM
#811   Thanks for the heads up. Disappointed with today's stark12 08/28/14 07:45:30 PM
#810   hello stark12, I know you have been following scstocks 08/28/14 01:57:46 PM
#809   Acusphere Withdraws its European Marketing Authorization Application for scstocks 08/28/14 12:53:11 PM
#808   just sold my last remaining shares on this scstocks 08/28/14 12:51:14 PM
#807   (EMEA/H/C/002347), (perflubutane), stark12 07/27/14 11:29:48 AM
#806   From the Yahoo stock discussion board: stark12 06/24/14 05:22:10 PM
#805   I've been holding my position for a long Hokane 06/18/14 02:23:58 PM
#804   Thanks! Not much action on this board. I'm stark12 06/10/14 10:41:03 PM
#803   Thanks for keeping up with the posts over scstocks 06/10/14 01:11:22 PM
#802 stark12 06/09/14 10:44:58 PM
#801   The Company has submitted the Marketing Authorisation Application stark12 06/08/14 01:14:58 PM
#800   From another stock message board: stark12 05/31/14 11:31:46 AM
#799   Hello people, tanjazielman 03/31/14 07:30:10 AM
#798 stark12 03/21/14 10:35:06 PM
#797   2 shares traded today. I would venture to stark12 02/19/14 09:29:04 PM
#796   On the Acusphere homepage it is listed as jugygales 01/26/14 09:55:13 AM
#795 This document says 1st quarter stark12 01/22/14 10:02:10 PM
#794 stark12 01/22/14 09:59:24 PM
#793   Pushed past 1.00 a couple of times today stark12 01/22/14 09:55:28 PM
#792   That works for me! stark12 01/13/14 02:04:04 AM
#791   got my sell order in for $20. Might whirly 01/12/14 06:56:32 PM
#790   Nice action today as we pushed past a stark12 01/09/14 10:42:05 PM
#789 stark12 11/23/13 11:39:33 AM
#788   this reminds me of VRML shurtha2000 10/01/13 10:23:23 AM
#787   Hello, I have been with Acusd almost 2 years. HUONG 09/28/13 07:48:51 PM
#786   This has been a good week for shareholders. stark12 09/27/13 10:35:12 PM
#785   >>> Acusphere Appoints Mark Leuchtenberger as President and CEO gfp927z 09/17/13 03:20:04 PM
#784   News: stark12 09/16/13 07:46:13 PM
#783   thanks gfp, memory not what is used to scstocks 05/21/13 04:10:13 PM
#782   SC, >>> review process is now underway gfp927z 05/21/13 10:33:16 AM
#781   ===validation process for the MAA has been successfully scstocks 05/16/13 09:25:39 PM
#780   Of the 5.1 million shares outstanding how many robsat1845 05/05/13 05:52:41 AM
#779   Looks like Acusphere was recently mentioned in a gfp927z 04/03/13 11:17:51 AM
#778   This one looks very good. Could see easy BERKSHIRE AGENT 04/02/13 11:07:18 PM
#777   I'm not sure when we will get any stark12 04/01/13 09:42:10 PM
#776   It would be nice to get an update tonyvanw 04/01/13 05:44:08 PM
#775   One can hope sc. Low volume so it's stark12 03/21/13 08:13:52 PM
#774   yikes, .55, thought it was a misprint as scstocks 03/21/13 12:53:01 PM
#773   Acusphere Announces Submission of Marketing Authorisation Application for scstocks 10/24/12 06:46:46 PM
#772   Miss your posts here sc. Hope things improve stark12 10/04/12 10:16:38 PM
#771   thanks for the posts stark12....i lost my spot scstocks 10/04/12 04:33:59 PM
#770   Volume of late has been rather low. Hoping stark12 10/03/12 08:07:56 PM
#769   News: LEXINGTON, Mass., Jul 09, 2012 (BUSINESS WIRE) -- stark12 07/09/12 09:32:29 AM
#768   ===I wonder what's up === scstocks 06/12/12 03:44:48 PM
#767   SC, I wonder what's up with the gfp927z 06/12/12 01:49:51 PM
#766   Was gone all day but could not get scstocks 05/22/12 08:19:28 PM
#765   Ouch! Closed a little over 21. Volume is stark12 05/22/12 08:02:13 PM
#764   I have added a few shares that way stark12 05/12/12 10:49:47 AM